
    
      A 16-weeks length, randomized, controlled, double-blind, parallel study designed to evaluate
      growth and tolerance of healthy infants fed milk-based infant formula. The study has been
      designed in accordance with Good Clinical Practice guidelines and the requirements of the
      Code of Federal Regulations 21 CFR 106.96
    
  